Residual vascular risk in diabetes – Will the SPPARM alpha concept hold the key?

Residual vascular risk in diabetes – Will the SPPARM alpha concept hold the key? / J.C. Fruchart, R.D. Santos, S. Yamashita, P. Libby, M. Aikawa, J. Plutzky, A. Pradhan, P. Ridker, C. Aguilar-Salinas, K. Al Rasadi, P. Amarenco, P.J. Barter, R. Ceska, A. Corsini, M. Ruscica, J.P. Despres, P. Duriez, R.H. Eckel, M.V. Ezhov, M. Farnier, H.N. Ginsberg, M.P. Hermans, S. Ishibashi, F. Karpe, T. Kodama, W. Koenig, M. Krempf, S. Lim, A.J. Lorenzatti, R. Mcpherson, J.M. Nunez-Cortes, B.G. Nordestgaard, H. Ogawa, C.J. Packard, C.I. Ponte-Negretti, Z. Reiner, S. Sadikot, H. Shimano, P. Sritara, J.K. Stock, T.C. Su, A.V. Susekov, A. Tartar, M.R. Taskinen, A. Tenenbaum, L.S. Tokgozoglu, B. Tomlinson, A. Tybjaerg-Hansen, P. Valensi, M. Vrablik, W. Wahli, G.F. Watts, K. Yokote, A. Zambon. - In: DIABETES & METABOLIC SYNDROME. - ISSN 1871-4021. - 13:4(2019 Aug), pp. 2723-2725. [10.1016/j.dsx.2019.05.034]